| Systemic complications of acromegaly: epidemiology, pathogenesis, and management A Colao, D Ferone, P Marzullo, G Lombardi Endocrine reviews 25 (1), 102-152, 2004 | 1721 | 2004 |
| Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary … ME Caplin, E Baudin, P Ferolla, P Filosso, M Garcia-Yuste, E Lim, ... Annals of Oncology 26 (8), 1604-1620, 2015 | 697 | 2015 |
| Persistence of increased cardiovascular risk in patients with Cushing’s disease after five years of successful cure A Colao, R Pivonello, S Spiezia, A Faggiano, D Ferone, M Filippella, ... The Journal of Clinical Endocrinology & Metabolism 84 (8), 2664-2672, 1999 | 572 | 1999 |
| ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms G Delle Fave, D O''Toole, A Sundin, B Taal, P Ferolla, JK Ramage, ... Neuroendocrinology 103 (2), 119-124, 2016 | 544 | 2016 |
| Well-differentiated pancreatic tumor/carcinoma: insulinoma WW de Herder, B Niederle, JY Scoazec, S Pauwels, G Klöppel, M Falconi, ... Neuroendocrinology 84 (3), 183-188, 2006 | 382 | 2006 |
| Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly A Colao, D Ferone, P Marzullo, P Cappabianca, S Cirillo, V Boerlin, ... The Journal of Clinical Endocrinology & Metabolism 86 (6), 2779-2786, 2001 | 367 | 2001 |
| ENETS consensus guidelines update for colorectal neuroendocrine neoplasms JK Ramage, WW De Herder, G Delle Fave, P Ferolla, D Ferone, T Ito, ... Neuroendocrinology 103 (2), 139-143, 2016 | 359 | 2016 |
| Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment A Colao, A Di Sarno, F Sarnacchiaro, D Ferone, G Di Renzo, B Merola, ... The Journal of Clinical Endocrinology & Metabolism 82 (3), 876-883, 1997 | 350 | 1997 |
| A consensus on the diagnosis and treatment of acromegaly comorbidities: an update A Giustina, A Barkan, A Beckers, N Biermasz, BMK Biller, C Boguszewski, ... The Journal of Clinical Endocrinology & Metabolism 105 (4), e937-e946, 2020 | 339 | 2020 |
| ENETS consensus guidelines for the standards of care in neuroendocrine tumors: biochemical markers D O’Toole, A Grossman, D Gross, G Delle Fave, J Barkmanova, ... Neuroendocrinology 90 (2), 194-202, 2009 | 322 | 2009 |
| Dopamine receptor expression and function in corticotroph pituitary tumors R Pivonello, D Ferone, WW de Herder, JM Kros, ML Del Basso De Caro, ... The Journal of Clinical Endocrinology & Metabolism 89 (5), 2452-2462, 2004 | 301 | 2004 |
| Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities E Resmini, F Minuto, A Colao, D Ferone Acta diabetologica 46, 85-95, 2009 | 285 | 2009 |
| Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database P Petrossians, AF Daly, E Natchev, L Maione, K Blijdorp, ... Endocrine-related cancer 24 (10), 505, 2017 | 276 | 2017 |
| Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy A Colao, R Baldelli, P Marzullo, E Ferretti, D Ferone, P Gargiulo, ... The Journal of Clinical Endocrinology & Metabolism 85 (1), 193-199, 2000 | 265 | 2000 |
| Acromegaly A Colao, B Merola, D Ferone, G Lombardi The Journal of Clinical Endocrinology & Metabolism 82 (9), 2777-2781, 1997 | 224 | 1997 |
| Effect of different dopaminergic agents in the treatment of acromegaly A Colao, D Ferone, P Marzullo, A Di Sarno, G Cerbone, F Sarnacchiaro, ... The Journal of Clinical Endocrinology & Metabolism 82 (2), 518-523, 1997 | 221 | 1997 |
| Characterization and subcellular localization of an RNA silencing suppressor encoded by Rice stripe tenuivirus R Xiong, J Wu, Y Zhou, X Zhou Virology 387 (1), 29-40, 2009 | 220 | 2009 |
| Novel insights in dopamine receptor physiology R Pivonello, D Ferone, G Lombardi, A Colao, SWJ Lamberts, LJ Hofland European journal of endocrinology 156 (Supplement_1), S13-S21, 2007 | 204 | 2007 |
| ENETS consensus guidelines for the standards of care in neuroendocrine tumors: biochemical markers K Oberg, A Couvelard, G Delle Fave, D Gross, A Grossman, RT Jensen, ... Neuroendocrinology 105 (3), 201-211, 2017 | 189 | 2017 |
| Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly F Gatto, RA Feelders, R van der Pas, JM Kros, M Waaijers, D Sprij-Mooij, ... The Journal of Clinical Endocrinology & Metabolism 98 (1), E66-E71, 2013 | 183 | 2013 |